Concepts (134)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optical Imaging | 10 | 2021 | 68 | 3.400 |
Why?
|
| Skin Neoplasms | 14 | 2020 | 404 | 3.300 |
Why?
|
| Methylene Blue | 11 | 2024 | 22 | 2.600 |
Why?
|
| Carcinoma, Basal Cell | 8 | 2020 | 63 | 2.210 |
Why?
|
| Microscopy, Confocal | 7 | 2015 | 226 | 2.100 |
Why?
|
| Fluorescence Polarization | 5 | 2024 | 32 | 1.720 |
Why?
|
| Skin | 6 | 2021 | 357 | 1.610 |
Why?
|
| Brain Neoplasms | 4 | 2015 | 305 | 1.360 |
Why?
|
| Breast Neoplasms | 4 | 2021 | 1118 | 1.200 |
Why?
|
| Microscopy, Polarization | 5 | 2018 | 7 | 1.200 |
Why?
|
| Microscopy, Fluorescence | 5 | 2021 | 392 | 1.130 |
Why?
|
| Terahertz Imaging | 3 | 2016 | 11 | 1.030 |
Why?
|
| Low-Level Light Therapy | 3 | 2023 | 8 | 0.980 |
Why?
|
| Coloring Agents | 5 | 2012 | 53 | 0.970 |
Why?
|
| Demeclocycline | 2 | 2015 | 4 | 0.950 |
Why?
|
| Mohs Surgery | 4 | 2020 | 52 | 0.940 |
Why?
|
| Multimodal Imaging | 2 | 2016 | 66 | 0.940 |
Why?
|
| Contrast Media | 4 | 2015 | 408 | 0.940 |
Why?
|
| Optics and Photonics | 3 | 2021 | 13 | 0.910 |
Why?
|
| Stomatitis | 1 | 2023 | 7 | 0.880 |
Why?
|
| Thyroid Neoplasms | 1 | 2024 | 71 | 0.880 |
Why?
|
| Skin Physiological Phenomena | 2 | 2021 | 16 | 0.740 |
Why?
|
| Collagen | 3 | 2018 | 115 | 0.730 |
Why?
|
| Light | 2 | 2021 | 198 | 0.730 |
Why?
|
| Temperature | 1 | 2021 | 295 | 0.650 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2020 | 237 | 0.590 |
Why?
|
| Image Enhancement | 2 | 2012 | 189 | 0.590 |
Why?
|
| Glioma | 2 | 2015 | 102 | 0.540 |
Why?
|
| Head and Neck Neoplasms | 1 | 2017 | 148 | 0.500 |
Why?
|
| Lasers, Semiconductor | 1 | 2015 | 3 | 0.500 |
Why?
|
| Cosmetic Techniques | 1 | 2015 | 9 | 0.500 |
Why?
|
| Skin Aging | 1 | 2015 | 9 | 0.500 |
Why?
|
| Mitochondria | 1 | 2019 | 343 | 0.490 |
Why?
|
| Biomarkers, Tumor | 1 | 2019 | 461 | 0.490 |
Why?
|
| Neoplasms | 2 | 2023 | 1240 | 0.480 |
Why?
|
| Sensitivity and Specificity | 6 | 2016 | 1093 | 0.470 |
Why?
|
| Margins of Excision | 3 | 2020 | 24 | 0.460 |
Why?
|
| Humans | 29 | 2024 | 59360 | 0.450 |
Why?
|
| Monte Carlo Method | 3 | 2023 | 87 | 0.410 |
Why?
|
| Carcinoma, Ductal, Breast | 1 | 2012 | 45 | 0.390 |
Why?
|
| Molecular Imaging | 1 | 2012 | 46 | 0.390 |
Why?
|
| Feasibility Studies | 4 | 2021 | 525 | 0.370 |
Why?
|
| Equipment Design | 5 | 2012 | 329 | 0.370 |
Why?
|
| Lasers | 2 | 2009 | 34 | 0.370 |
Why?
|
| Carcinoma | 1 | 2012 | 115 | 0.370 |
Why?
|
| Tetracycline | 2 | 2009 | 22 | 0.350 |
Why?
|
| Tomography, Optical Coherence | 1 | 2012 | 209 | 0.340 |
Why?
|
| Aged | 9 | 2020 | 13416 | 0.330 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2024 | 654 | 0.320 |
Why?
|
| Middle Aged | 10 | 2020 | 16317 | 0.320 |
Why?
|
| Dysplastic Nevus Syndrome | 1 | 2009 | 2 | 0.320 |
Why?
|
| Female | 12 | 2021 | 30705 | 0.310 |
Why?
|
| Melanoma | 2 | 2009 | 329 | 0.290 |
Why?
|
| Pilot Projects | 5 | 2018 | 914 | 0.290 |
Why?
|
| Spectrophotometry, Infrared | 1 | 2006 | 26 | 0.270 |
Why?
|
| Reproducibility of Results | 4 | 2015 | 1561 | 0.270 |
Why?
|
| Adult | 8 | 2020 | 15669 | 0.270 |
Why?
|
| Aged, 80 and over | 5 | 2020 | 5128 | 0.260 |
Why?
|
| Male | 12 | 2020 | 27739 | 0.250 |
Why?
|
| Image Interpretation, Computer-Assisted | 1 | 2007 | 168 | 0.250 |
Why?
|
| Staining and Labeling | 4 | 2007 | 124 | 0.240 |
Why?
|
| Disease Models, Animal | 3 | 2010 | 2050 | 0.230 |
Why?
|
| Cytodiagnosis | 1 | 2024 | 44 | 0.230 |
Why?
|
| Thyroid Gland | 1 | 2024 | 79 | 0.220 |
Why?
|
| Radiometry | 1 | 2023 | 35 | 0.220 |
Why?
|
| Intraoperative Period | 2 | 2012 | 33 | 0.200 |
Why?
|
| Tolonium Chloride | 3 | 2007 | 3 | 0.190 |
Why?
|
| Brain | 3 | 2015 | 1488 | 0.190 |
Why?
|
| Thermal Conductivity | 1 | 2021 | 5 | 0.180 |
Why?
|
| Cell Line, Tumor | 2 | 2019 | 1370 | 0.180 |
Why?
|
| Equipment Failure Analysis | 2 | 2012 | 74 | 0.180 |
Why?
|
| Scattering, Radiation | 1 | 2021 | 72 | 0.180 |
Why?
|
| Mice, Inbred BALB C | 1 | 2021 | 868 | 0.160 |
Why?
|
| In Vitro Techniques | 3 | 2011 | 471 | 0.150 |
Why?
|
| Immunohistochemistry | 3 | 2016 | 847 | 0.150 |
Why?
|
| Wound Healing | 2 | 2010 | 174 | 0.140 |
Why?
|
| Adipose Tissue | 2 | 2012 | 283 | 0.140 |
Why?
|
| Diagnosis, Differential | 2 | 2012 | 937 | 0.140 |
Why?
|
| Sampling Studies | 1 | 2016 | 65 | 0.130 |
Why?
|
| Biopsy, Needle | 1 | 2016 | 132 | 0.130 |
Why?
|
| Rejuvenation | 1 | 2015 | 2 | 0.130 |
Why?
|
| Laser Therapy | 2 | 2006 | 36 | 0.130 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 21 | 0.120 |
Why?
|
| Fluorescent Dyes | 2 | 2015 | 196 | 0.120 |
Why?
|
| Radionuclide Imaging | 1 | 2015 | 121 | 0.120 |
Why?
|
| Meningeal Neoplasms | 1 | 2015 | 58 | 0.120 |
Why?
|
| Meningioma | 1 | 2015 | 59 | 0.120 |
Why?
|
| Neoplasm Metastasis | 1 | 2015 | 188 | 0.110 |
Why?
|
| Brain Chemistry | 1 | 2014 | 77 | 0.110 |
Why?
|
| Mice | 3 | 2021 | 10292 | 0.110 |
Why?
|
| Glioblastoma | 1 | 2015 | 155 | 0.100 |
Why?
|
| Fibroblasts | 2 | 2012 | 377 | 0.100 |
Why?
|
| Rose Bengal | 2 | 2010 | 7 | 0.100 |
Why?
|
| Animals | 6 | 2021 | 19651 | 0.100 |
Why?
|
| Biopsy | 1 | 2012 | 411 | 0.090 |
Why?
|
| Models, Statistical | 1 | 2012 | 298 | 0.090 |
Why?
|
| Dermatitis, Phototoxic | 1 | 2010 | 2 | 0.090 |
Why?
|
| Tissue Adhesives | 1 | 2010 | 9 | 0.090 |
Why?
|
| Biomarkers | 1 | 2015 | 1306 | 0.080 |
Why?
|
| Dermatologic Surgical Procedures | 1 | 2010 | 34 | 0.080 |
Why?
|
| Chromogenic Compounds | 1 | 2009 | 1 | 0.080 |
Why?
|
| Aging | 1 | 2015 | 710 | 0.080 |
Why?
|
| Dermatology | 1 | 2010 | 70 | 0.080 |
Why?
|
| Cell Nucleus | 1 | 2012 | 608 | 0.070 |
Why?
|
| Cross-Sectional Studies | 1 | 2014 | 2373 | 0.070 |
Why?
|
| Time Factors | 1 | 2015 | 3617 | 0.070 |
Why?
|
| Dermis | 1 | 2006 | 16 | 0.070 |
Why?
|
| Phototherapy | 1 | 2006 | 34 | 0.070 |
Why?
|
| Achilles Tendon | 1 | 2005 | 7 | 0.060 |
Why?
|
| Port-Wine Stain | 1 | 2005 | 10 | 0.060 |
Why?
|
| Photochemotherapy | 1 | 2005 | 20 | 0.060 |
Why?
|
| Tendon Injuries | 1 | 2005 | 17 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4267 | 0.060 |
Why?
|
| Mice, Inbred C57BL | 1 | 2010 | 3231 | 0.050 |
Why?
|
| Swine | 2 | 2010 | 352 | 0.040 |
Why?
|
| Predictive Value of Tests | 1 | 2018 | 1025 | 0.030 |
Why?
|
| Skin Absorption | 1 | 2010 | 16 | 0.020 |
Why?
|
| Photosensitizing Agents | 1 | 2010 | 14 | 0.020 |
Why?
|
| Random Allocation | 1 | 2010 | 192 | 0.020 |
Why?
|
| Reference Values | 1 | 2010 | 326 | 0.020 |
Why?
|
| Rabbits | 1 | 2010 | 322 | 0.020 |
Why?
|
| Cell Survival | 1 | 2010 | 559 | 0.020 |
Why?
|
| Dose-Response Relationship, Radiation | 1 | 2007 | 52 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2007 | 179 | 0.020 |
Why?
|
| Electrons | 1 | 2006 | 34 | 0.020 |
Why?
|
| Glucose | 1 | 2010 | 445 | 0.020 |
Why?
|
| Analysis of Variance | 1 | 2007 | 589 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2010 | 2093 | 0.020 |
Why?
|
| Rupture | 1 | 2005 | 22 | 0.020 |
Why?
|
| Tensile Strength | 1 | 2005 | 28 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2005 | 574 | 0.010 |
Why?
|
| Rats | 1 | 2005 | 1910 | 0.010 |
Why?
|
| Risk Factors | 1 | 2010 | 4984 | 0.010 |
Why?
|
| Adolescent | 1 | 2005 | 5824 | 0.010 |
Why?
|